CliffBio
small molecule

FENOFIBRIC ACID

CHOLINE FENOFIBRATE

Loss of exclusivity—loss of exclusivity
CompanyTWI PHARMACEUTICALS INC

Drug detail

Brand nameFENOFIBRIC ACID
Active ingredientCHOLINE FENOFIBRATE
StrengthEQ 45MG FENOFIBRIC ACID
Dosage formCAPSULE, DELAYED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2019
Marketing statusDISCN

More from TWI PHARMACEUTICALS INC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.